A 60-month non-comparative study on bleeding profiles with the levonorgestrel intrauterine system from the late transition period to estrogen supplemented menopause

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 153, Issue 2, 2010, Pages 176-180

  Depypere, Herman T ^a   Hillard, Timothy ^b   Erkkola, Risto ^c   Lukkari Lax, Eeva ^d   Kunz, Michael ^e   Rautiainen, Pia ^d   Schram, Jan H N ^f  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b POOLE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d Bayer Schering Pharma Oy   (Finland)

^e BAYER PHARMA AG   (Germany)

^f ALBERT SCHWEITZER HOSPITAL   (Netherlands)

Author keywords

LNG IUS during menopausal transition

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; LEVONORGESTREL;

ADULT; ARTICLE; BELGIUM; CLIMACTERIUM; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTRACEPTION; DRUG EFFICACY; ENDOMETRIUM; ESTROGEN THERAPY; FEMALE; FINLAND; GYNECOLOGIC DISEASE; HUMAN; INTRAMURAL MYOMATA; MENOPAUSAL SYNDROME; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUATION; MULTICENTER STUDY; NETHERLANDS; NORMAL HUMAN; PRIORITY JOURNAL; REPRODUCTION; SPOTTING; TREATMENT OUTCOME; UNITED KINGDOM; VAGINA BLEEDING;

EID: 78249274616     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2010.08.017     Document Type: Article

References (11)

1. I. Persson, H.O. Adami, L. Bergkvist, A. Lindgren, B. Petterson, and R. Hoover Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study Br Med J 298 1989 147 151
2. T.H. Raudaskoski, E.I. Tomás, I.A. Paakkari, A.J. Kauppila, and T.J. Laatikainen Serum lipids and lipoproteins in postmenopausal women receiving transdermal oestrogen in combination with a levonorgestrel-releasing intrauterine device Maturitas 22 1995 47 53
3. The Writing Group for the PEPI Trial Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women JAMA 273 1995 199 208
4. F.R. Pérez-López, P. Chedraui, J.J. Gilbert, and G. Pérez-Roncero Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era Fertil Steril 92 2009 1171 1186
5. P. Eiken, and N. Kolthoff Compliance with long-term oral hormonal replacement therapy Maturitas 22 1995 97 103
6. S.G. Silverberg, M. Haukkamaa, H. Arko, C.G. Nilsson, and T. Luukkainen Endometrial morphology during long-term use of the levonorgestrel-releasing intrauterine device Int J Gynaecol Pathol 5 1986 235 241
7. K. Andersson, V. Odlind, and G. Rybo Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial Contraception 49 1994 56 72
8. A.E. Lethaby, I. Cooke, and M. Rees Progesterone/progestogen intrauterine releasing systems for heavy menstrual bleeding The Cochrane Library: Issue 3 2007 John Wiley & Sons, Ltd. Chichester, UK
9. Scholten PC, Christiaens GCML, Haspels AA. Treatment of menorrhagia by intrauterine administration of levonorgestrel. In: Scholten PC, editor. The Levonorgestrel IUD. Clinical performance and impact on menstruation Dissertation. Utrecht; 1989. 94 pp.
10. S.M. McKinlay, D.J. Brambilla, and J.G. Posner The normal menopausal transition Maturitas 14 1992 103 115
11. M. Hunter, R. Battersby, and M. Whitehead Relationships between psychological symptoms, somatic complaints and menopausal status Maturitas 8 1986 217 228